Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - AXA INVESTMENT MANAGERS: Loungers plc
-
CERo Therapeutics Holdings, Inc. Highlights Progress
-
Richtech Robotics Announces Grand Opening of Clouffee & Tea in Las Vegas
-
MMA.inc on Track to Achieve US$0.75 Million1 in Warrior Training Program Gross Sales for the March 25 Quarter, Driven by Record-Breaking 200% YoY Growth2
-
Richtech Robotics Announces Grand Opening of Clouffee & Tea in Las Vegas
-
CERo Therapeutics Holdings, Inc. Highlights Progress
-
Notification of managers and closely related parties’ transactions with A.P. Møller - Mærsk A/S shares
-
Bad Data Makes Bad Decisions: 58% of Leaders Report Companies Using Inaccurate Data for Big Decisions
-
Shiplify Launches Self-Service Product to Revolutionize LTL for Shippers
-
Ashvattha to Present at Upcoming Angiogenesis, Exudation, and Degeneration 2025 and BIO CEO Conferences
-
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
-
Ferroglobe PLC Schedules Fourth Quarter and Full-year 2024 Earnings Call for February 20, 2025
-
Zscaler to Host Second Quarter Fiscal Year 2025 Earnings Conference Call
-
Commure and North East Medical Services (NEMS) Partner to Revolutionize Clinical Documentation with Full Epic Integration
-
LKQ Corporation Appoints Sue Gove and Michael Powell to its Board
-
Enphase Energy Expands its Support for Grid Services Programs Across North America
-
EnsembleIQ’s Product of the Year Canada Announces 2025 Award Winners
-
AT&T and TransUnion Launch In-Network Branded Call Display with Reason for Call
-
Torr Metals Closes Final Tranche of Private Placement
-
Actuate Therapeutics to Participate in Upcoming Investor Conferences in February
-
NV5 Awarded $5 Million in Substation Design Contracts by Northeast Utilities
-
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Auto
-
Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
-
electroCore Expands Intellectual Property Portfolio
-
BermudAir Becomes the Only Airline Offering Nonstop Flights from Montreal to Bermuda
-
Barfresh Secures $3 Million in Profitable Growth Financing
-
Shirofune Joins IAB US as Official Member, Strengthening North American Presence
-
Aqua Metals Strengthens Board of Directors to Advance Sustainable Battery Recycling and Critical Minerals Production
-
Futurex Tops ABI Research’s Payment HSM Competitive Assessment with #1 Ranking in Innovation
-
Galecto to Participate in Upcoming Investor Conferences
-
Nano Dimension Announces Update to its Board of Directors
-
Bermuda's Air Carrier Expands Reach With New Nonstop Routes
-
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
-
Idaho National Laboratory Testing of FuelCell Energy’s Electrolyzer to Show Further Commercialization Opportunity for Nuclear Power Plants
-
Monarch Private Capital Announces Successful $275 Million Bond Issuance Led by HSBC
-
AT&T and TransUnion Launch In-Network Branded Call Display with Reason for Call
-
LVT Bolsters Executive Leadership Amid Rapid Company Growth And Surging Demand for Advanced Security Tech
-
Playtika Announces Date of Fourth Quarter 2024 Results Conference Call
-
CAMP4 to Participate in Upcoming Investor Conferences
-
Duck Creek Technologies Receives Insurance Business America’s 2025 5-Star Diversity, Equity, and Inclusion Award for Third Straight Year
-
Mass General Brigham’s Kraft Center Announces the 2025 Kraft Prize for Excellence and Innovation in Community Health
-
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call Thursday, Feb. 27, 2025
-
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Acronis Appoints Stephen Nichols as Country Manager for Canada
-
Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
-
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
-
Bermuda's Air Carrier Expands Reach With New Nonstop Routes
-
NB Private Equity: Holding(s) in Company
-
X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia
-
FTI Delta Strengthens Telecommunications Practice with Two Senior Hires
